ReviewBMC gastroenterology2021

Long-term survival of a patient with microsatellite-stable refractory colorectal cancer with regorafenib and PD-1 inhibitor sintilimab: a case report and review of literature.

Yong Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.